Aveo Pharmaceuticals Lawsuit

Merger News

Levi & Korsinsky Investigating Invuity Merger; IVTY Acquisition

Levi & Korsinsky

September 26, 2018

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Invuity, Inc. (“Invuity” or the “Company”) (NASDAQGM: IVTY)to Stryker Corporation (NYSE: SYK) for $7.40 in cash per share. To learn more about the Invuity merger investigation and your rights, go tohttps://www.zlk.com/mna/invuity-inc-2 or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The Invuity merger investigation concerns whether the Board of Invuity breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Stryker Corporation is underpaying for Invuity shares, thus unlawfully harming Invuity shareholders.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

 

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com